File Sharing


How Egnyte Uses AWS to Create An Innovative Approach to Storage, Collaboration, Security and Compliance

The life sciences industry is undergoing major transitions. Pharma, biotech, and medical device companies generate more data than ever and require higher processing power for clinical trials, gene sequencing and more. Many life sciences organizations are transitioning legacy technology stacks to the cloud, which promises the ability to accelerate processes, mobile collaboration, and strong security. To further complicate matters, there is increasing pressure to maintain regulatory compliance.


Replace GxP SFTP/file servers with modern solutions for validated environments

Data is the lifeblood of the life sciences. As therapeutics, medical devices, and diagnostics advance from early-stage development into clinical testing and beyond, the scrutiny of reported data and procedures dramatically increases. Dating back to the 1990s, many pharmaceutical and biotech companies have implemented systems and processes to store, exchange, and analyze regulated data from environments governed by GxP (e.g, clinical trials, manufacturing, toxicology, etc.).


Zero-Day Ransomware Detection is a Necessity, Not a Luxury

No one is a stranger to the notion of security. We protect our homes and physical assets with locks and cameras and are vigilant when we encounter abnormal behavior. But for some reason, the data entrusted to us is not always given the same type of protection. That data has become a prime target for cybercriminals which is manifested in the form of ransomware attacks, which are increasingly prevalent.


Egnyte Metadata Intelligence Provides Structure to Your Enterprise Content

The great management thinker, W. Edwards Deming, famously said something to the effect of, “If you can’t measure it, you can’t manage it.” It’s hard to argue with Deming’s logic, but there’s a consideration that comes before measurement, and that’s discovery. Before anyone measures or manages anything, they have to be able to accurately find and understand the things being measured, managed, improved, and transacted.


3 Things to Consider When Looking for a Secure Content Platform

Business leaders who are responsible for providing users with access to their company’s intellectual property also realize the importance of keeping it secure. They are also likely championing the advantages of digital transformation as a way to improve their own company’s operations while delivering a more secure environment for data, workloads, and users.


Do Files Matter to your Business?

Do Files Matter? As Chief Customer Officer of Egnyte, I get to meet many of our customers and influencers. This is immensely invigorating for two reasons – it helps me get our POV out to the market in an old school, door to door sort of way but more importantly, keeps me on an arc of continuous learning to shape our approach to the market. While this process has played out well over the last several years I have simply run out of time to meet everyone as Egnyte grows.


How Westmont College Leveraged Egnyte During One of The Worst Natural Disasters in The State of California

On December 23, 2017 the Thomas Fire, which at the time was the largest wildfire in the history of the State of California, approached the Santa Barbara campus of Westmont College. Students, faculty, and staff could see the smoke in the near distance and the ashes falling on campus. It was as if the sky was literally falling. Clearly, this was no ordinary forest fire—if there is such a thing as an ordinary forest fire.


Monitoring AWS FSx with LogicMonitor

Amazon FSx is a fast, highly available cloud file system service. Compared to traditional file systems, AWS FSx offers improved performance along with simplified management and security. The use of this service removes the headaches of provisioning hardware and maintaining backups, and combines the familiarity of your preferred filesystems with the reliability of AWS.


Collaboration in the modern biotech era

The life sciences industry has rapidly changed over the past twenty years. Drug development, historically, used to rely on vertically-integrated institutions that spanned scientific functions. However, today, products are launched by emerging startups, vast companies and any size in between. To improve velocity and agility, research is increasingly outsourced to academia and external partnerships beyond the traditional confines of a company.